DK95291A - Rekombinante dna-molekyler - Google Patents

Rekombinante dna-molekyler Download PDF

Info

Publication number
DK95291A
DK95291A DK095291A DK95291A DK95291A DK 95291 A DK95291 A DK 95291A DK 095291 A DK095291 A DK 095291A DK 95291 A DK95291 A DK 95291A DK 95291 A DK95291 A DK 95291A
Authority
DK
Denmark
Prior art keywords
dna molecules
polypeptides
carrier protein
human
processes
Prior art date
Application number
DK095291A
Other languages
Danish (da)
English (en)
Other versions
DK95291D0 (da
Inventor
Emerald Martin Spencer
Carol Talkingtonverser
Original Assignee
Biogrowth Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23115154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK95291(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogrowth Inc filed Critical Biogrowth Inc
Publication of DK95291D0 publication Critical patent/DK95291D0/da
Publication of DK95291A publication Critical patent/DK95291A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK095291A 1988-12-22 1991-05-21 Rekombinante dna-molekyler DK95291A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29025088A 1988-12-22 1988-12-22
PCT/US1989/005791 WO1990006950A1 (fr) 1988-12-22 1989-12-21 Molecules d'adn recombinant, hotes, procedes et polypeptides similaires a des proteines porteuses de somatomedine humaine

Publications (2)

Publication Number Publication Date
DK95291D0 DK95291D0 (da) 1991-05-21
DK95291A true DK95291A (da) 1991-08-16

Family

ID=23115154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK095291A DK95291A (da) 1988-12-22 1991-05-21 Rekombinante dna-molekyler

Country Status (14)

Country Link
EP (2) EP0451194B1 (fr)
JP (2) JPH04503352A (fr)
KR (1) KR910700261A (fr)
AT (1) ATE155793T1 (fr)
AU (1) AU4836890A (fr)
CA (1) CA2006322C (fr)
DE (1) DE68928203T2 (fr)
DK (1) DK95291A (fr)
ES (1) ES2107422T3 (fr)
GR (1) GR3025094T3 (fr)
HK (1) HK1000826A1 (fr)
IL (1) IL92816A0 (fr)
WO (1) WO1990006950A1 (fr)
ZA (1) ZA899832B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6403764B1 (en) 1999-01-06 2002-06-11 Genentech, Inc. Insulin-like growth factor-1 protein variants
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
AU762047B2 (en) 1999-01-06 2003-06-19 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
WO2001087323A2 (fr) 2000-05-16 2001-11-22 Genentech, Inc. Procede de traitement des lesions du cartilage
WO2002072780A2 (fr) 2001-03-14 2002-09-19 Genentech, Inc. Peptides antagonistes d'igf
JP2007535895A (ja) 2003-05-01 2007-12-13 イムクローン システムズ インコーポレイティド ヒトインシュリン様成長因子−１受容体に対する完全ヒト抗体
DK2274978T3 (en) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
WO2005033132A2 (fr) 2003-10-03 2005-04-14 Genentech, Inc. Proteines de liaison a l'igf
KR20080047529A (ko) 2005-06-17 2008-05-29 임클론 시스템즈 인코포레이티드 전이성 골암 치료를 위한 수용체 길항제
AU2007212447B2 (en) 2006-02-03 2013-02-21 Imclone Llc IGF-IR antagonists as adjuvants for treatment of prostate cancer
CN111432881A (zh) 2017-09-11 2020-07-17 夏尔人类遗传性治疗公司 用于治疗慢性肺病的方法和组合物
EP4228676A1 (fr) 2020-10-19 2023-08-23 Oak Hill Bio Limited Compositions appropriées pour une utilisation chez des nouveau-nés
WO2023139115A1 (fr) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions et procédés pour réduire l'oxydation d'igf‐1/igfbp
WO2023242440A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Traitement des poumons chez les nourrissons
WO2023242439A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Stabilisation vasculaire (nourrissons prématurés)
WO2023242442A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Procédé de maturation/différenciation de neurones et/ou de modulation du nerf vague
WO2024170612A1 (fr) 2023-02-14 2024-08-22 Oak Hill Bio Limited Traitement de la dérégulation de cicatrisation dans un tissu gi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
CA1322714C (fr) * 1986-11-14 1993-10-05 Harry N. Antoniades Cicatrisation et regeneration osseuse
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5057417A (en) * 1987-06-12 1991-10-15 Genentech, Inc. Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
EP0409858B1 (fr) * 1988-03-17 1993-12-08 Novo Nordisk A/S Proteines liant l'heparine, adn codant pour ces proteines, leurs procedes de production ainsi que des preparations therapeutiques les contenant
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
EP0418230B1 (fr) * 1988-04-12 1995-12-27 Amgen Boulder Inc. Procede de potentialisation et d'inhibition de l'activite de facteurs de croissance du type insuline

Also Published As

Publication number Publication date
HK1000826A1 (en) 1998-05-01
GR3025094T3 (en) 1998-01-30
WO1990006950A1 (fr) 1990-06-28
EP0375438A3 (fr) 1992-03-25
JPH11236400A (ja) 1999-08-31
CA2006322C (fr) 2000-08-01
ZA899832B (en) 1990-10-31
CA2006322A1 (fr) 1990-06-22
AU4836890A (en) 1990-07-10
JPH04503352A (ja) 1992-06-18
EP0451194B1 (fr) 1997-07-23
ES2107422T3 (es) 1997-12-01
KR910700261A (ko) 1991-03-14
EP0451194A4 (en) 1992-09-02
IL92816A0 (en) 1990-09-17
EP0375438A2 (fr) 1990-06-27
ATE155793T1 (de) 1997-08-15
EP0451194A1 (fr) 1991-10-16
DE68928203D1 (de) 1997-09-04
DK95291D0 (da) 1991-05-21
DE68928203T2 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
DK95291A (da) Rekombinante dna-molekyler
DK677688D0 (da) Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne
IL92257A0 (en) Binding proteins for insulin-like growth factors,pharmaceutical compositions containing them and dna fragments encoding them
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
FI102768B1 (fi) Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin valmistamiseksi
DE68926888D1 (de) Verfahren zur Herstellung von sekretierten Rezeptoranalogen
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
WO1995021919A3 (fr) Proteine a activite de thrombopoietine (tpo)
FI103892B1 (fi) Rekombinantti-DNA-molekyyli, joka koodaa polypeptidiä/proteiinia, jolla on oleellisesti vaskulaaristen antikoaguloivien proteiinien biologiset ominaisuudet sekä niiden valmistus
DE69637148D1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
DE3855084D1 (de) Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
EP0546074A4 (en) Genetic material encoding igfbp-5
FI921600A (fi) Bjoerkpollenallergen p14 foer diagnos och behandling av allergiska sjukdomar.
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
EP0546053A4 (en) Genetic material encoding igfbp-4
EP0261403A3 (fr) Polypeptide de rhinovirus souche HRV89, et molécule d'ADN qui l'encode
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
WO1995008628A3 (fr) Acides nucleiques codant la merosine, fragments de merosine et utilisations de ceux-ci
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
IL78278A0 (en) Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules
Spencer et al. Uses for antibodies which bind to human somatomedin carrier protein subunits